Drugs for Precocious Puberty (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 40)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Megestrol acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
595-33-5 |
11683 |
Synonyms:
17-ACETOXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE
17ALPHA-ACETOXY-6-DEHYDRO-6-METHYLPROGESTERONE
17ALPHA-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE ACETATE
17-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE 17-ACETATE
17Α-ACETOXY-6-DEHYDRO-6-METHYLPROGESTERONE
17Α-HYDROXY-6-METHYLPREGNA-4,6-DIENE-3,20-DIONE ACETATE
5071
6-DEHYDRO-6-METHYL-17ALPHA-ACETOXYPROGESTERONE
6-DEHYDRO-6-METHYL-17Α-ACETOXYPROGESTERONE
6-METHYL-17ALPHA-ACETOXYPREGNA-4,6-DIENE-3,20-DIONE
6-METHYL-17ALPHA-HYDROXY-DELTA(SUP 6)-PROGESTERONE ACETATE
6-METHYL-17Α-ACETOXYPREGNA-4,6-DIENE-3,20-DIONE
6-METHYL-17Α-HYDROXY-DELTA(SUP 6)-PROGESTERONE ACETATE
6-METHYL-6-DEHYDRO-17ALPHA-ACETOXYPROGESTERONE
6-METHYL-6-DEHYDRO-17Α-ACETOXYPROGESTERONE
6-METHYL-DELTA(SUP 4,6)-PREGNADIEN-17ALPHA-OL-3,20-DIONE ACETATE
6-METHYL-DELTA(SUP 4,6)-PREGNADIEN-17Α-OL-3,20-DIONE ACETATE
6-METHYL-DELTA(SUP 6)-DEHYDRO-17ALPHA-ACETOXYPROGESTERONE
6-METHYL-DELTA(SUP 6)-DEHYDRO-17Α-ACETOXYPROGESTERONE
|
BDH-1298
MAGESTIN
MAYGACE
MEGACE
MEGACE ES
MEGERON
MEGESTAT
MEGESTIL
MEGESTIN
MEGESTROL
MEGESTROL ACETATE
MGA
NIA
NIAGESTIN
NSC-71423
OVABAN
OVARID
SC-10363
VOLIDAN
|
|
2 |
|
Leuprolide |
Approved, Investigational |
Phase 4 |
|
53714-56-0 |
657181 |
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
ABBOTT-43818
ABBOTT-43818 FREE BASE
ABBOTT-43818|Fensolvi® (leuprolide acetate injectable suspension)|Lupron®|TAP-144
Acetate, leuprolide
CKD-841
Enantone
Leuprolide
Leuprolide acetate
Leuprolide monoacetate
Leuprolide, (DL-leu)-isomer
Leuprolide, (L-leu)-isomer
Leuprorelin
|
Leuprorelin acetate
Leuprorelina
Leuproreline
Leuprorelinum
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
Lupron
Monoacetate, leuprolide
NSC-377526
PGlu-his-TRP-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-TRP-ser-tyr-D-leu-leu-arg-pro-nhet
TAP 144
TAP-144
TAP-144 FREE BASE
|
|
3 |
|
Megestrol |
|
Phase 4 |
|
3562-63-8 |
3080587 19090 |
Synonyms:
17-HDHPG
17-Hydroxy-6-dehydroprogesterone
17-Hydroxy-6-dehydroprogesterone, (9beta,10alpha)-isomer
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione
CHRONOPIL
Magestin
MEGACE
Megeron
Megestrol acetate
|
Megestrolo
Megestrolum
Megestryl acetate
MGA
Niagestin
Ovaban
Ovarid
Volidan
|
|
4 |
|
Central Nervous System Stimulants |
|
Phase 4 |
|
|
|
5 |
|
Contraceptives, Oral, Hormonal |
|
Phase 4 |
|
|
|
6 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
7 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
8 |
|
Hormone Antagonists |
|
Phase 3 |
|
|
|
9 |
|
Prolactin Release-Inhibiting Factors |
|
Phase 3 |
|
|
|
10 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
11 |
|
Contraceptive Agents |
|
Phase 3 |
|
|
|
12 |
|
Triptorelin Pamoate |
|
Phase 3 |
|
|
|
Synonyms:
|
TRIPTORELIN EMBONATE
TRIPTORELIN PAMOATE
|
|
13 |
|
(R)-Bicalutamide |
Approved, Experimental |
Phase 2 |
|
90357-06-5, 113299-40-4 |
2375 |
Synonyms:
(-)-Bicalutamide
4'-Cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide
Astra brand OF bicalutamide
AstraZeneca brand OF bicalutamide
BICALUTAMIDA
BICALUTAMIDE
BICALUTAMIDUM
CALUTIDE
Calutide®|Casodex®
|
Casodex
Cosudex
ICI 176334
ICI176,334-1
ICI-176334
KALUMID
ZD7054
Zeneca brand OF bicalutamide
|
|
14 |
|
Anastrozole |
Approved, Investigational |
Phase 2 |
|
120511-73-1 |
2187 |
Synonyms:
2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
a,a,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
Anastrazole
Anastrole
Anastrozol
ANASTROZOLE
Arimidex
Arimidex®
Astra brand OF anastrozole
|
AstraZeneca brand OF anastrozole
ICI D1033
ICI-D1033
NASTROSA
ZD1033
ZD-1033
Zeneca brand OF anastrozole
Zeneca ZD 1033
Α,α,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
α,α,α',α'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
|
|
15 |
|
Testolactone |
Approved, Investigational |
Phase 2 |
|
968-93-4 |
13769 |
Synonyms:
(4AS,4BR,10ar,10BS,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4BH)-dione
1 Dehydrotestolactone
1,2-Dehydrotestololactone
1,2-Didehydrotestololactone
13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oate delta-lactone
13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oate Δ-lactone
13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone
13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid Δ-lactone
1-Dehydrotestolactone
1-Dehydrotestololactone
delta(1)-Testolactone
delta(1)-Testololactone
delta1-Dehydrotestololactone
delta1-Testolactone
delta1-Testololactone
|
D-homo-17a-Oxaandrosta-1,4-diene-3,17-dione
FLUDESTRIN
NSC-23759
SQ-9538
SQ-9538|Teslac®
Teslac
Testolactona
Testolactone
TESTOLACTONE CIII
Testolactonum
Testolattone
Δ(1)-testololactone
Δ1-Dehydrotestololactone
Δ1-Testolactone
Δ1-Testololactone
|
|
16 |
|
Spironolactone |
Approved |
Phase 2 |
|
1952-01-7, 52-01-7 |
5833 |
Synonyms:
ABBOLACTONE
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone a
Aldactone®|spiractin|spirotone
Alderon
Aldopur
Almatol
Alphapharm brand OF spironolactone
Alpharma brand OF spironolactone
Alter brand OF spironolactone
Altex
Aquareduct
Ashbourne brand OF spironolactone
Azupharma brand OF spironolactone
Betapharm brand OF spironolactone
Cardel brand OF spironolactone
CAROSPIR
CT Arzneimittel brand OF spironolactone
CT, Spiro von
CT-Arzneimittel brand OF spironolactone
Deverol
Dexo brand OF spironolactone
DIATENSEC
Dira
Duraspiron
Espironolactona
Espironolactona [INN-Spanish]
Espironolactona alter
Espironolactona mundogen
Euteberol
Flumach
Frumikal
Generosan brand OF spironolactone
GX SPIRONOL
Hormosan brand OF spironolactone
Jenapharm brand OF spironolactone
Jenaspiron
Lacalmin
Lacdene
LARACTONE
Mayoly-spindler brand OF spironolactone
Melarcon
Merck dura brand OF spironolactone
Mundogen brand OF spironolactone
Nefurofan
Novo spiroton
Novopharm brand OF spironolactone
Novo-spiroton
NovoSpiroton
NSC-150399
Osyrol
Pfizer brand OF spironolactone
|
Pharmafrid brand OF spironolactone
Practon
Roche brand OF spironolactone
Sagisal
SC-9420
Searle brand OF spironolactone
Sincomen
SNL
Spiractin
Spiresis
SPIRETIC
Spiridon
SPIRNOLACTONE
Spiro l.u.t.
Spiro von CT
Spirobeta
Spiroctan
SPIROCTAN 100
SPIROCTAN 25
SPIROCTAN 50
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono isis
Spironocompren
Spirono-isis
SPIRONOLACTONE
Spironolactone [BAN:INN:JAN]
Spironolactone A
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
SPIROSPARE 100
SPIROSPARE 25
Spiro-Tablinen
SPIROTONE
Sprioderm
Supra-puren
Suracton
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
Von CT, spiro
Wörwag brand OF spironolactone
Xenalon
|
|
17 |
|
Testosterone |
Approved, Investigational |
Phase 2 |
|
58-22-0 |
5408 6013 |
Synonyms:
(+-)-8-ISO-TESTOSTERONE
(+-)-RETROTESTOSTERONE
(+)-TESTOSTERONE
(+-)-TESTOSTERONE
(17B)-17-HYDROXY-ANDROST-4-EN-3-ONE
(1S,2R,10R,11S,14S,15S)-14-HYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
13-ISO-TESTOSTERONE
17 beta Hydroxy 4 androsten 3 one
17 beta Hydroxy 8 alpha 4 androsten 3 one
17A-HYDROXY-(13A)-ANDROST-4-EN-3-ONE
17A-HYDROXY-13A-ANDROST-4-EN-3-ONE
17A-HYDROXY-14B-ANDROST-4-EN-3-ONE
17A-HYDROXY-ANDROST-4-EN-3-ONE
17-beta-Hydroxy-4-androsten-3-one
17BETA-HYDROXY-4-ANDROSTEN-3-ONE
17-beta-Hydroxy-8 alpha-4-androsten-3-one
17B-HYDROXY-(10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(13A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(8A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(8A,10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(9B)-ANDROST-4-EN-3-ONE
17B-HYDROXY-(9B,10A)-ANDROST-4-EN-3-ONE
17B-HYDROXY-13A-ANDROST-4-EN-3-ONE
17b-Hydroxy-4-androsten-3-one
17B-HYDROXY-8A-ANDROST-4-EN-3-ONE
17B-HYDROXY-ANDROST-4-EN-3-ON
17B-HYDROXYANDROST-4-EN-3-ONE
17B-HYDROXY-ANDROST-4-EN-3-ONE
17B-HYDROXYANDROST-4-ENE-3-ONE
17B-HYDROXY-D4-ANDROSTEN-3-ONE
17B-TESTOSTERONE
17-HYDROXY-10,13-DIMETHYL-1,2,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE
17-HYDROXY-ANDROST-4-EN-3-ONE
17-HYDROXY-D4-ANDROSTEN-3-ONE
17Β-hydroxy-4-androsten-3-one
4-ANDROSTEN-17BETA-OL-3-ONE
4-Androsten-17b-ol-3-one
4-ANDROSTEN-17Β-OL-3-ONE
4-ANDROSTEN-3-ONE-17B-OL
8 Isotestosterone
8-Isotestosterone
8-ISO-TESTOSTERONE
9B,10A-TESTOSTERONE
9B-TESTOSTERONE
Andriol
Andro
Andro 100
Andro L.A. 200
ANDRODERM
Androderm®|Delatestryl®
ANDROGEL
ANDROGEL 1%
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
ANDROPATCH
Andropository 200
Androsorb
ANDROST-4-EN-17B-OL-3-ONE
ANDROST-4-ENE-17B-OL-3-ONE
Androtop
Andrusol
Andryl 200
AstraZeneca brand OF testosterone
Auxilium pharmaceuticals inc. brand OF testosterone
AXIRON
Bartor brand OF testosterone
Beta Testosterone
Bio-T-Gel
CDB 111C
CEPA brand OF testosterone
Cristerona T
Cristerone T
D4-ANDROSTEN-17B-OL-3-ONE
Dea No. 4000
Delatest
DELATESTRYL
Depotest
Depo-Testosterone
Depo-Testosterone Cypionate
Dr. kade brand OF testosterone
Epitestosteron
Everone 200
Faulding brand OF testosterone
Ferring brand OF testosterone
FORTESTA
Geno-cristaux gremy
GlaxoSmithKline brand OF testosterone
Hauck brand OF testosterone
Histerone
Homosteron
Homosterone
INTRINSA
Libigel
LUMITESTOSTERON
|
Malerone
Malestrone
Malogen in Oil
Malogen, Aquaspension Injection
MERTESTATE
Metandren
Methyltestosterone
NATESTO
Neo-Hombreol F
Neotestis
Neo-Testis
NSC-9700
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Ortho brand OF testosterone
Paladin brand OF testosterone
Pasadena brand OF testosterone
Perandren
Percutacrine androgenique
Primotest
Primoteston
RAC-17B-HYDROXY-(13A)ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-(8A)-ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-(9B,10A)ANDROST-4-EN-3-ONE
RAC-17B-HYDROXY-ANDROST-4-EN-3-ONE
Relibra
RETROTESTOSTERONE
Scheinpharm Testone-Cyp
Schering brand OF testosterone
SmithKline beecham brand OF testosterone
Solvay brand OF testosterone
Sterotate
STRIANT
STRIANT SR
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
TESTIM
TESTIM 1%
Testobase
TESTODERM
TESTODERM TTS
TESTOGEL
Testoject-50
Testolent
Testolin
TESTOPATCH
TESTOPEL
Testopel Pellets
Testopropon
TESTORAL
Testosteroid
TESTOSTERON
TESTOSTERONA
Testosterona [INN-Spanish]
TESTOSTERONE
TESTOSTÉRONE
TESTOSTERONE CIII
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone sulfate
TESTOSTERONUM
Testosteronum [INN-Latin]
Testostosterone
Testoviron
Testoviron schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
Testro aq
TESTRONE
Testryl
TOSTRAN
Tostrelle
Tostrex
Trans-Testosterone
Ulmer brand OF testosterone
Unimed brand OF testosterone
Viatrel
Virilon
Virilon IM
Virormone
VIROSTERONE
VOGELXO
Watson brand OF testosterone
|
|
18 |
|
Fulvestrant |
Approved, Investigational |
Phase 2 |
|
129453-61-8 |
17756771 104741 |
Synonyms:
(1S,9R,11S,14S,15S)-15-Methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulphinyl)nonyl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,4,6-triene-5,14-diol
(7α,17β)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol
7-(9-(4,4,5,5,5-Pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex
Faslodex®|ICI 182,780|ICI 182780|ICI182780|ZD-9238
|
FULVESTRANT
ICI 182,780
ICI-182780
SID29215034
ZD-9238
|
|
19 |
|
Deslorelin |
Investigational, Vet_approved |
Phase 2 |
|
57773-65-6 |
25077495 |
Synonyms:
DESLORELIN
Deslorelina
Desloreline
Deslorelinum
|
D-TRP LHRH-PEA
D-TRP-LHRH-PEA
SOMAGARD [AS ACETATE]
|
|
20 |
|
Androgen Antagonists |
|
Phase 2 |
|
|
|
21 |
|
Aromatase Inhibitors |
|
Phase 2 |
|
|
|
22 |
|
Diuretics, Potassium Sparing |
|
Phase 2 |
|
|
|
23 |
|
diuretics |
|
Phase 2 |
|
|
|
24 |
|
Mineralocorticoids |
|
Phase 2 |
|
|
|
25 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 2 |
|
|
|
26 |
|
Estrogens |
|
Phase 2 |
|
|
|
27 |
|
Estrogen Receptor Antagonists |
|
Phase 2 |
|
|
|
28 |
|
Estrogen Antagonists |
|
Phase 2 |
|
|
|
29 |
|
Letrozole |
Approved, Investigational |
Phase 1 |
|
112809-51-5 |
3902 |
Synonyms:
4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)
CGS-20267
FEM345
Femara
Fémara
|
Femara®
Letrozol
LETROZOLE
Novartis brand OF letrozole
|
|
30 |
|
Ganirelix |
Approved |
Early Phase 1 |
|
124904-93-4 |
44208957 16186319 16130966 |
Synonyms:
D 24598|D-24598|Orgalutran®|RS 26306|RS-26306
GANIRELIX
GANIRELIX ACETATE
GANIRELIX ACETATE INJECTION
|
ORGALUTRAN
RS-26306
RS-26306-298
|
|
31 |
|
Racepinephrine |
Approved, Vet_approved |
|
|
51-43-4, 329-65-7 |
838 5816 |
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]BENZYL ALCOHOL(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]-BENZYL ALCOHOL
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenaline
(−)-ADRENALINE
(-)-Epinephrine
(+-)-Adrenaline
(+-)-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(−)-ADRENALINE
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
2-(Methylamino)-1-(3,4-dihydroxyphenyl)ethanol
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-HYDROXY-2-METHYLAMINOETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]PYROCATECHOL
Acetate, epinephrine
Adnephrine
ADREN CO
ADRENACLICK
Adrenal
Adrenalin
adrenalin|Auvi-Q®|Epipen®|l-adrenaline|L-epinephrine|levoepinephrine
Adrenaline
Adrénaline
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
adrenaline|epinephrine
Adrenine
Adrin
Allergan brand OF adrenaline hydrochloride
ANA-GUARD
Ana-kit
ANAPEN
ANAPHYLACTIC SHOCK DRUG KIT
ASMA-VYDRIN
ASTHMAHALER
Auvi-Q
Bird brand OF racepinefrine hydrochloride
Bosmin
Bronkaid mist
BROVON
Chelafrin
DL-Adrenaline
EMERADE
EPI E Z PEN JR
Epifrin
Epiglaufrin
Epinefrin
Epinefrina
Epinephran
Epinephrin
EPINEPHRINE
Epinephrine acetate
Epinephrine bitartrate
EPINEPHRINE HCL
Epinephrine hydrochloride
Epinephrine hydrochloride, racemic mixture
Epinephrine hydrogen tartrate
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Epinephrinum
Epipen
|
EPIPEN E Z PEN
Epipen JR
EPIPEN JR.
Epirenan
Epitrate
Eppy
Exadrin
Glauposine
GPPE INH SOLN
Hemisine
Hemostasin
Hemostatin
Hydrochloride, racepinephrine
Hypernephrin
Isoptoepinal
JEXT
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-DETHYLAMINOETHANOLCATECHOL
L-Epinephrine
L-Epirenamine
Levoepinephrine
LEVO-METHYLAMINOETHANOLCATECHOL
Levorenen
Levorenin
Levorenine
Levoreninum
L-Methylaminoethanolcatechol
Lyodrin
Lyophrin
Medihaler-epi
Methylarterenol
Micronefrin
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Mucidrina
Nephridine
Nieraline
NSC-62786
Paranephrin
Primatene
Primatene mist
R-(-)-Epinephrine
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Renaglandin
Renaleptine
Renalina
Renoform
Renostypticin
Renostyptin
RIDDOBRON
RIDDOFAN
RYBARVIN
Scurenaline
Simplene
SOLN MADE TO RYBARVIN FOR
Styptirenal
Supracapsulin
Supranephrane
Suprarenaline
Suprarenin
Surrenine
Sus-phrine
SUS-PHRINE SULFITE FREE
SUS-PHRINE SULFITE-FREE
SYMJEPI
Takamina
TWINJECT
TWINJECT 0.15
TWINJECT 0.3
Vaponefrin
Vasoconstrictine
Vasotonin
|
|
32 |
|
Metformin |
Approved |
|
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
33 |
|
Tin Fluorides |
|
|
|
|
|
34 |
|
Liver Extracts |
|
|
|
|
|
35 |
|
Follicle Stimulating Hormone |
|
Early Phase 1 |
|
|
|
36 |
|
Androgens |
|
|
|
|
|
37 |
|
Epinephryl borate |
|
|
|
|
|
38 |
|
Tea |
|
|
|
|
|
39 |
|
Hormones |
|
|
|
|
|
40 |
|
Hypoglycemic Agents |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 55)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Analysis of Body Mass Index in Central Precocious Puberty(CPP) Patients Treated With Leuprolide Acetate |
Unknown status |
NCT02974270 |
Phase 4 |
Leuprolide |
2 |
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children |
Unknown status |
NCT00438217 |
Phase 4 |
Triptorelin (GnRH agonists);Leuprolide (GnRH agonists) |
3 |
A Multicenter, Open, Prospective Study to Evaluate the Safety and Efficacy of Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty |
Completed |
NCT03316482 |
Phase 4 |
Leuplin DPS 11.25mg |
4 |
An Open Label, Multicenter Study to Assess the Safety and Efficacy of Leuprorelin in the Treatment of Central Precocious Puberty |
Completed |
NCT02427958 |
Phase 4 |
Leuprorelin |
5 |
The Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty; A Single, Open, Multi-center, Prospective Study |
Completed |
NCT01634321 |
Phase 4 |
Luphere depot 3.75mg(Leuprolide acetate 3.75mg) |
6 |
Multi-site Study of Comprehensive Treatment for Children Precocious Puberty |
Completed |
NCT02920515 |
Phase 4 |
Triptorlin or Leuprorelin;Zhibo dihuang pills;Dabu ying pills |
7 |
Evidence-based Medical Research on the Treatment of Children's Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine |
Recruiting |
NCT03963752 |
Phase 4 |
Ziyinxiehuo Granules Herbs;Megestrol Acetate Tablet;Leuprorelin Acetate 3.75mg Injection |
8 |
An Open Label, Multicenter, Single-arm and Prospective Study to Assess the Efficacy and Safety of Leuprorelin 3M in the Treatment of Central Precocious Puberty (CPP) |
Not yet recruiting |
NCT05341115 |
Phase 4 |
Leuprorelin Acetate Depot 3M |
9 |
A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children With Central Precocious Puberty |
Completed |
NCT00667446 |
Phase 3 |
Leuprolide Acetate 3 Month Depot |
10 |
A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children With Central Precocious Puberty |
Completed |
NCT00635817 |
Phase 3 |
Leuprolide acetate 11.25 mg;Leuprolide acetate 30 mg |
11 |
An Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of Triptorelin 3-month Formulation in Chinese Children With Central Precocious Puberty |
Completed |
NCT04736602 |
Phase 3 |
Triptorelin pamoate 15mg |
12 |
Study of Lupron Depot In The Treatment of Central Precocious Puberty |
Completed |
NCT00660010 |
Phase 3 |
Lupron (leuprolide acetate) |
13 |
Phase III, Open-Label Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Children With Central Precocious Puberty |
Completed |
NCT00779103 |
Phase 3 |
Histrelin Subcutaneous Implant |
14 |
Phase III, Multicentre, Non-comparative, Open and Single Stage Study to Assess the Efficacy and Safety of Pamoate of Triptorelin 11.25 MG in Children With Precocious Puberty |
Completed |
NCT00564850 |
Phase 3 |
Triptorelin pamoate 11.25mg (Decapeptyl® SR) |
15 |
Follow-up of the Phase III, Multicentre, Non Comparative, One Single Group, Open Study to Assess the Long-term Efficacy and Tolerability of Pamoate of Triptorelin 11.25 mg in Children With Precocious Puberty |
Completed |
NCT00909844 |
Phase 3 |
Triptorelin (I.N.N.) |
16 |
An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty |
Completed |
NCT02452931 |
Phase 3 |
Leuprolide Acetate 45 mg |
17 |
An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty |
Completed |
NCT01467882 |
Phase 3 |
Triptorelin |
18 |
Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls. |
Completed |
NCT01278290 |
Phase 3 |
|
19 |
A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Depot Formulation in Children With Central Precocious Puberty (CPP) |
Active, not recruiting |
NCT03695237 |
Phase 3 |
Leuprolide Acetate (LA) |
20 |
A Phase III, Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Chinese Paediatric Participants With Central Precocious Puberty. |
Active, not recruiting |
NCT05029622 |
Phase 3 |
Triptorelin Pamoate |
21 |
An Open-label, Single Arm, Multicenter, Phase III Study on the Efficacy, Safety, and Pharmacokinetics of FP-001 42 mg Controlled Release in Patients With Central (Gonadotropin-Dependent) Precocious Puberty |
Not yet recruiting |
NCT05493709 |
Phase 3 |
Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide |
22 |
An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination With Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys With Testotoxicosis |
Completed |
NCT00094328 |
Phase 2 |
Bicalutamide;Anastrozole |
23 |
Testolactone Treatment of Girls With LHRH Analog-Resistant Precocious Puberty Due to Autonomous, Non-Neoplastic Ovarian Estrogen Secretion |
Completed |
NCT00001181 |
Phase 2 |
Testolactone |
24 |
Spironolactone and Testolactone Treatment of Boys With Familial Isosexual Precocious Puberty |
Completed |
NCT00001202 |
Phase 2 |
Spironolactone;Testolactone;Deslorelin |
25 |
An Open-label Study Evaluating the Safety and Efficacy of Anastrozole™ (ARIMIDEX) in the Treatment of Precocious Puberty in Girls With McCune-Albright Syndrome |
Completed |
NCT00055302 |
Phase 2 |
Arimidex 1 mg |
26 |
An Open-label, Non-Comparative Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Faslodex (Fulvestrant) in Girls With Progressive Precocious Puberty Associated With McCune-Albright Syndrome |
Active, not recruiting |
NCT00278915 |
Phase 2 |
Fulvestrant |
27 |
Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS) |
Completed |
NCT00006174 |
Phase 1 |
Letrozole |
28 |
A Randomized, Single-blinded, Parallel Design Phase I Clinical Trial to Investigate the Safety and Pharmacokinetics/Pharmacodynamics of CKD-841 A-1, CKD-841 D or Leuplin Inj. After Subcutaneous Injection in Postmenopausal Female |
Not yet recruiting |
NCT04840745 |
Phase 1 |
CKD-841 A-1 3.75mg;CKD-841 A-1 1.88mg;CKD-841 D 2.92mg;Leuplin Inj. 3.75 mg |
29 |
Follow-up of Girls With Premature Thelarche and Precocious Puberty: a Clinical and Paraclinical Study of Girls With Thelarche and Healthy Controls |
Unknown status |
NCT01944475 |
|
|
30 |
Influence of Early Adiposity Rebound, Genetic Polymorphisms and GnRHa Treatment on Long-term Outcome of Girls With Idiopathic Central Precocious Puberty. |
Unknown status |
NCT02790112 |
|
|
31 |
Urinary LH in the Diagnosis of Precocious Puberty |
Unknown status |
NCT01800565 |
|
|
32 |
THE EFFICACY OF PREOPERATIVE USAGE OF GONADOTROPINE-RELEASING HORMONE AGONIST IN PATIENTS UNDERGOING TOTAL LAPAROSCOPIC HYSTERECTOMY DUE TO UTERIN FIBROIDS |
Unknown status |
NCT04192812 |
|
PREOPERATİVE GnRHa THERAPY (LEUPROLIDE ACETATE) BEFORE SURGERY FOR UTERİN FIBROIDS;NO GnRHa |
33 |
LH Response to GnRH Test in Prepubescent Girls Under 6 Years |
Unknown status |
NCT01944488 |
|
GnRH agonist |
34 |
An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty |
Completed |
NCT02993926 |
|
Enantone;GnRH agonist |
35 |
Efficacy of Experienced Chinese Herbal Formulas for the Treatment of Different Types of Precocious Puberty: A Single-blinded Randomized Controlled Trial |
Completed |
NCT02650141 |
|
ziyinxiehuo Granules;zishenqinggan Granules |
36 |
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Precocious Puberty |
Completed |
NCT02431416 |
|
Gonadotropin releasing hormone (GnRH);Sodium Chloride |
37 |
Purification of Testis-Stimulating Factor in Precocious Puberty |
Completed |
NCT00004344 |
|
leuprolide;testosterone |
38 |
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty |
Completed |
NCT00734279 |
Early Phase 1 |
Leuprolide Acetate - Early Puberty Leuprolide Visit;Ganirelix - Early Puberty Ganirelix Visit;Ganirelix - Delayed Puberty Ganirelix Visit;Leuprolide Acetate- Delayed Puberty Leuprolide Visit |
39 |
Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle |
Completed |
NCT00004335 |
|
|
40 |
The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or Growth Hormone Provocation Test |
Completed |
NCT02199587 |
|
|
41 |
Molecular Basis of Inherited Reproductive Disorders |
Completed |
NCT00494169 |
|
|
42 |
Polymorphisms in the Kisspeptin/GPR54 Pathway Genes and the Risk of Early Puberty |
Completed |
NCT04012632 |
|
|
43 |
Polymorphisms in Obesity-related Genes Are Associated With Risk of Early Puberty in Han Chinese Girls |
Completed |
NCT04317014 |
|
|
44 |
Qualitative Assessment of the Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years |
Completed |
NCT01679925 |
|
|
45 |
The Effect of Childhood Overweight and Obesity and Genetic Factors on Puberty Development: a Prospective Cohort Study |
Recruiting |
NCT04113070 |
|
|
46 |
Effect of Prevalence of Overweight and Obesity(Body Mass Index (BMI)) on Efficacy of Herbal Medicines(ZiYinXieHuo) in Girls' Sexual Precocity |
Recruiting |
NCT04665713 |
|
|
47 |
The Genetics of Neuroendocrine Reproductive Disorders and of the Cleft Lip and/or Palate |
Recruiting |
NCT01601171 |
|
|
48 |
Natural History Study of Patients With Excess Androgen |
Recruiting |
NCT00250159 |
|
|
49 |
Effect of Exogenous Growth Hormone on Ocular Findings of Children With Precocious and Early Puberty: a Prospective Cohort Study |
Recruiting |
NCT05338411 |
|
|
50 |
Evaluation of the Correlation Between Psychological Intervention, Including Providing Knowledge and Tools for Problems Solving, and the Anxiety Level of Female Patients Arriving to ACTH LRH Test - Pilot Study |
Recruiting |
NCT04502836 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Gonadorelin
Gonadorelin Acetate
Gonadorelin Hydrochloride
Leuprolide
Leuprolide Acetate
|
Nafarelin
Nafarelin Acetate
Tamoxifen
Tamoxifen Citrate
|
|